XML 30 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
Selected Balance Sheet Information
12 Months Ended
Dec. 31, 2024
Selected Balance Sheet Information  
Selected Balance Sheet Information

6. Selected Balance Sheet Information

PREPAID EXPENSES AND OTHER CURRENT ASSETS (in thousands):

    

December 31, 

    

December 31, 

2024

2023

Prepaid manufacturing expenses

$

375

$

491

Prepaid insurance

374

496

Prepaid clinical research organizations

365

1,119

Prepaid consulting, subscriptions and other expenses

235

180

VAT receivable

 

95

 

128

Total prepaid expenses and other current assets

$

1,444

$

2,414

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services.

PROPERTY AND EQUIPMENT (in thousands)

    

December 31, 

    

December 31, 

2024

2023

Computers and office equipment

$

708

$

902

Other property, plant and equipment

392

417

Leasehold improvements

 

94

 

94

Software

 

11

 

11

 

1,205

 

1,424

Less: accumulated depreciation and amortization

 

(935)

 

(1,002)

 

  

 

  

Total property and equipment, net

$

270

$

422

During the years ended December 31, 2024 and 2023 the Company recognized depreciation expense of $137,000 and 135,000 respectively.

ACCRUED EXPENSES (in thousands)

    

December 31, 

    

December 31, 

2024

2023

Accrued clinical consulting services

$

2,390

$

1,700

Accrued manufacturing costs

772

843

Accrued vendor payments

206

452

 

  

 

  

Total accrued expenses

$

3,368

$

2,995

ACCRUED EMPLOYEE BENEFITS (in thousands)

    

December 31, 

    

December 31, 

2024

2023

Accrued bonus expense

$

870

$

1,307

Accrued compensation expense

 

187

 

127

Accrued vacation expense

87

83

 

  

  

Total accrued employee benefits

$

1,144

$

1,517